Intellipharmaceutics International Inc., has announced the second quarter results for FY-2015~16.
The results shows fall in Revenues by 14.2% down to $1.27 Million YoY and EPS down by -$0.02 to -$0.06.
The Company recorded net loss for the three months ended May 31, 2015 of $1.5 million or $0.06 per diluted common share, compared with a net loss of $3.1 million or $0.14 per common share for the three months ended May 31, 2014. The net loss for the three months ended May 31, 2015, is $1.6 million lower than the comparable prior period primarily due to reduced stock-based compensation and bonus expense, and tighter overall cost control.
Fiscal Q2 2015 Highlights vs. Same Year-ago Quarter
Total revenues down by 14.2% to $1.27 million down from $1.4 million
Net Loss was down to $1.5 million or $0.06 per share, from net loss of $3.1 million or $0.14.
Cash of $3.0 million on May 31, 2015 down from $4.2 Million on February 28, 2015.
View the full earnings release here.